The conclusion of Lifecore Biomedical's strategic evaluation process, coupled with the announcement of management succession and board changes, likely led to uncertainty among investors, resulting in a negative impact on the stock price. Such corporate changes often lead to short-term volatility as the market reacts to the potential implications for the company's future direction and governance.